Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Open | $17.04 |
Close | $17.11 |
Volume / Avg. | 7.14M / 16.84M |
Day Range | 16.82 - 17.81 |
52 Wk Range | 3.53 - 23.86 |
Market Cap | $2.51B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 27.17% |
Days to Cover | 4.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
There is no analysis for Novavax.
Novavax has a consensus price target of $54.43.
The stock price for Novavax (NASDAQ: NVAX) is $17.07 last updated July 26, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.